DHEA can suppress various cancers through different mechanisms, including inhibition of the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) pathway and induction of the autophagic cell death of liver cancer (Jiang et al., 2005; Vegliante et al., 2016). The gene discussed is AKT1; the disease is liver cancer.